TRAIL GUIDE
Our experts score the debate: How Clinton beat Trump, round-by-round
Topics

U.S. Securities and Exchange Commission

Mylan's EpiPen profit was 60% higher than what the CEO told Congress

Mylan's EpiPen profit was 60% higher than what the CEO told Congress

Lawmakers were skeptical last week when Mylan’s chief executive said that the company made only $100 in profit for a two-pack of EpiPens. During a House hearing, she repeatedly referred to a poster board showing how little of the $608 list price trickled back to the company.

The incredulity was warranted: The profit CEO Heather Bresch told Congress about was calculated after factoring in the 37.5% U.S. tax rate, according to a filing with the Securities and Exchange Commission first reported by the Wall Street Journal.

That tax rate is more than five times the...

89°